Organic compounds -- part of the class 532-570 series – Organic compounds – Heterocyclic carbon compounds containing a hetero ring...
Patent
1994-04-28
1996-02-06
Dees, Jose G.
Organic compounds -- part of the class 532-570 series
Organic compounds
Heterocyclic carbon compounds containing a hetero ring...
562446, 562435, C07D21700
Patent
active
054896860
ABSTRACT:
This invention relates to novel substituted 1,2,3,4-tetrahydroisoquinolines which are useful in the treatment of vascular restenosis, various disorders of the central nervous system, in the regulation of female reproductive functions, in cognitive enhancement, in atherosclerosis and in treating excessive AVP secretory disorders. Novel intermediates useful in the preparation of the compounds are also disclosed. Methods of using the compounds and pharmaceutical compositions containing them are disclosed.
REFERENCES:
patent: 4812462 (1989-03-01), Blankley
patent: 5236934 (1993-08-01), VanAtten
Chem. Abstracts 103:178147, Miyake et al., 1984.
Chem. Abstracts 95:42934, Oka et al., 1980.
Chem. Abstracts 95:7084, Takeda Chemical Industries, 1980.
M. K. VanAtten, et al., 1,2,3,4-Tetrahydroisoquinoline-3-Carboxylic Acids as Novel, Selective Inhibitor of Angiotensin II Binding to the AT.sub.2 Site. Aug. 22-27, 1993.
Am. J. Med., 76:4-12 (1984), W. P. Castelli, "Epidemiology of Coronary Heart Disease . . . ".
Hypertension 9:178-187 (1987), G. K. Owens, "Influence of Blood Pressure on Development of Aortic . . . ".
Science 245:186-188 (1989), J. S. Powell et al., "Inhibitors of Angiotensin-Converting . . . ".
Hypertension 18 [Suppl II]:II65-II69 (1991), A. W. Clowes, "Heparin and Cilazapril Together Inhibit . . . ".
ibid, :II60-II64, W. Osterrieder et al., "Role of Angiotensin II in Injury-Induced Neointima . . . ". 1990.
J. Card. Pharmacol., 16(4):S42-S49 (1990), J. W. Powell, "The Proliferative Response to Vascular Injury . . . ".
Hypertension, 18[Supp. II]:II55-II59 (1991), J. Clozel, "Inhibition of Converting Enzyme and Neointima . . . ".
ibid, :II47-II54, D. Plissonnier et al., "Effect of Converting Enzyme Inhibition . . . ", 1991.
ibid, :II43-II46, S. Roux, "Cilazapril Inhibits Wall Thickening of Vein Bypass Graft in the Rat", 1991.
Clin. Cardiol., 13:VII-43-48 (1990), A. V. Chobanian, "The Effects of ACE Inhibitors and Other . . . ".
J. Card. Phrmacol. 15(5):S65-S72, G. Aberg et al., "Effects of Captopril on Atherosclerosis . . . ", 1990.
J. Clin. Invest., 83:1419-1424 (1989), A. Naftilan et al., "Induction of Platelet-derived Growth . . . ".
Biochem. Biophys. Res. Comm., 165(1):196-203 (1989), A. Chiu et al., "Identification of Angiotensin . . . ".
ibid., 172(3):1195-1202 (1990), A. Chiu et al., "[3H]DUP 753, a highly potent and specific . . . ".
Molecular Pharm., 38:370-377 (1990), D. Dudley et al., "Subclasses of Angiotensin II Binding Sites and . . . ".
Am. J. Pathology, 139(6):1291-1296 (1991), M. Prescott et al. "Angiotensin-converting Enzyme Inhibitor . . . ".
Life Sciences, 49:PL-223--PL-228 (1991), R. Kauffman, "Losartan, a Nonpeptide Angiotensin . . . ".
J. Clin. Invest., 88:921-933 (1991) E. Grady et al., "Expression of AT2 Receptors in the Developing . . . ".
Biochem. Biophys. Res. Comm., 179(3):1361-1367 (1991), M. Viswanathan et al., "Changes in Expression . . . ".
Ann. Rev. Physiol., 49:413-435 (1987), M. I. Phillips, "Function of Angiotensin in the Central . . . ".
Brain Res., 507:341-343 (1990), J. Barnes et al., "Angiotensin II inhibits acetylcholine . . . ".
Pharm. Biochem & Behavior, 33:573-579 (1989), B. Costall, "The Effects of ACE Inhibitors Captopril . . . ".
Hypertension, 17:425 (1991), Schiavone et al.
Psychosomatic Medicine 35:143-154 (1973), D. Janowsky et al. "Correlations Between Mood, Weight, . . . ".
Biochemical Pharmacology, 42(4):715-719 (1991), P. Andrade-Gordon, "Role of Angiotensin . . . ".
Blankley Clifton J.
Hodges John C.
Klutchko Sylvester
Anderson Elizabeth M.
Barts Samuel
Dees Jos,e G.
Warner-Lambert & Company
LandOfFree
Substituted 1,2,3,4-tetrahydroisoquinolines with angiotensin II does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Substituted 1,2,3,4-tetrahydroisoquinolines with angiotensin II , we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Substituted 1,2,3,4-tetrahydroisoquinolines with angiotensin II will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-2175970